XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Business Segment and Geographical Information (Tables)
3 Months Ended
Apr. 02, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] Business Segment Information
Three months ended
April 2,April 3,
(In millions)20222021
Revenues
Life Sciences Solutions
$4,231 $4,203 
Analytical Instruments
1,518 1,387 
Specialty Diagnostics
1,482 1,615 
Laboratory Products and Biopharma Services
5,442 3,597 
Eliminations
(855)(896)
Consolidated revenues
11,818 9,906 
Segment Income
Life Sciences Solutions
2,176 2,279 
Analytical Instruments
301 272 
Specialty Diagnostics
353 428 
Laboratory Products and Biopharma Services
620 531 
Subtotal reportable segments
3,450 3,510 
Cost of revenues adjustments
(11)(8)
Selling, general and administrative expenses adjustments
(7)(16)
Restructuring and other costs
(2)(14)
Amortization of acquisition-related intangible assets
(609)(423)
Consolidated operating income
2,821 3,049 
Interest income 18 12 
Interest expense(136)(125)
Other income/(expense)
(163)(183)
Income before income taxes
$2,540 $2,753 
Cost of revenues adjustments included in the above table consist of charges for the sale of inventories revalued at the date of acquisition. Selling, general and administrative expenses adjustments included in the above table consist of third-party transaction/integration costs related to recent acquisitions, and charges/credits for changes in estimates of contingent acquisition consideration.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Business Segment Information
Three months ended
April 2,April 3,
(In millions)20222021
Revenues
Life Sciences Solutions
$4,231 $4,203 
Analytical Instruments
1,518 1,387 
Specialty Diagnostics
1,482 1,615 
Laboratory Products and Biopharma Services
5,442 3,597 
Eliminations
(855)(896)
Consolidated revenues
11,818 9,906 
Segment Income
Life Sciences Solutions
2,176 2,279 
Analytical Instruments
301 272 
Specialty Diagnostics
353 428 
Laboratory Products and Biopharma Services
620 531 
Subtotal reportable segments
3,450 3,510 
Cost of revenues adjustments
(11)(8)
Selling, general and administrative expenses adjustments
(7)(16)
Restructuring and other costs
(2)(14)
Amortization of acquisition-related intangible assets
(609)(423)
Consolidated operating income
2,821 3,049 
Interest income 18 12 
Interest expense(136)(125)
Other income/(expense)
(163)(183)
Income before income taxes
$2,540 $2,753 
Cost of revenues adjustments included in the above table consist of charges for the sale of inventories revalued at the date of acquisition. Selling, general and administrative expenses adjustments included in the above table consist of third-party transaction/integration costs related to recent acquisitions, and charges/credits for changes in estimates of contingent acquisition consideration.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Three months ended
April 2,April 3,
(In millions)20222021
Revenues
United States
$6,097 $4,892 
China
910 775 
Other
4,811 4,239 
Consolidated revenues
$11,818 $9,906